Experimental approaches to the function of tumor-associated lymphatic vessels [0.03%]
肿瘤相关淋巴管功能的实验研究方法
Yubo Liang,Xingming Chen,Jin Li et al.
Yubo Liang et al.
Decoding prostate cancer therapy resistance and novel therapeutic strategies [0.03%]
破解前列腺癌治疗耐药及新型治疗策略zych
Haojie Huang
Haojie Huang
Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance [0.03%]
前列腺癌进展和治疗抵抗中AR-FOXA1信号转导的改变
Shuai Gao,Nolan D Patten,Changmeng Cai
Shuai Gao
The androgen receptor (AR) is instrumental in the onset and progression of prostate cancer (PCa), establishing androgen deprivation therapy (ADT) as the first-line treatment for metastatic disease. However, the effectiveness of ADT is commo...
Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer [0.03%]
前列腺癌中的转录和表观重编程、谱系可塑性及治疗抗性
Yujun Shuai,Haojie Huang
Yujun Shuai
Prostate cancer is the most commonly diagnosed and the second-leading cause of cancer-related mortality in men worldwide, especially in Western counties. Therapeutic resistance of prostate cancer remains a major challenge in modern oncology...
Reframing the ozone-lung cancer link: toward exposure equity in urban China [0.03%]
中国城市空气中臭氧与肺癌关联的再思考：走向接触公平之路
Man Sun,Dan Zang,Jun Chen
Man Sun
Restoring dendritic cell interstitial motility via PDE5 inhibition for sustained antitumor immunity [0.03%]
通过PDE5抑制恢复树突状细胞间质运动以维持抗肿瘤免疫反应
Ruichen Zang,Chen Zhang,Guoqing Ding et al.
Ruichen Zang et al.
Do ethnic disparities exist in disease burden and healthcare utilization of male breast cancer? A 9-year cohort study of 9.08 million adults in China [0.03%]
中国1亿成人中9年队列研究:男性乳腺癌的民族差异是否导致疾病负担和卫生服务利用不同？
Jieying Chen,Liying Qiao,Ying Yan et al.
Jieying Chen et al.
Background: As a rare disease, male breast cancer (MBC) is of increasing concern in China. Whether health inequalities of disease burden and healthcare utilization exist by ethnicity in male breast cancer remains unclear....
Baiyang Liu,Yongbin Chen
Baiyang Liu
Conditional relative survival: an essential tool for risk stratification of (breast) cancer patients [0.03%]
条件相对生存率：(乳腺)癌症患者风险分层的重要工具
Luigino Dal Maso,Annalisa Trama,Fabiola Giudici et al.
Luigino Dal Maso et al.
Reply: reframing the ozone-lung cancer link: toward exposure equity in urban China [0.03%]
关于重新解读臭氧与肺癌的关系以及在中国城市实现暴露公平性的回复
Yi Wu,Chunqi Wang,Chunxiao Xu et al.
Yi Wu et al.